The Latest in Type 2 Diabetes ICYMI

Study links childhood type 1 diabetes to increased AD risk

September 22, 2015

Diabetes

Empagliflozin’s triumph respins FDA’s diabetes drug mandate

September 21, 2015

Diabetes

Diabetic foot ulcer: Early closure post debridement best

September 21, 2015

Diabetes

‘Artificial beta-cell’ insulin systems post more positive data

September 18, 2015

Diabetes

EASD: SGLT2 inhibitor empagliflozin cuts CV risk in patients with type 2 diabetes

September 18, 2015

Diabetes

When stepping up type 2 treatment, GLP-1 agonists have the edge

September 17, 2015

Diabetes

When Stepping up Type 2 Treatment, GLP-1 Agonists Have the Edge

September 17, 2015

Diabetes

No difference in long-term cost for diabetes treatment with bariatric surgery

September 17, 2015

Diabetes

Liraglutide/metformin targets glycemic goal in type 2 diabetes

September 16, 2015

Diabetes

Liraglutide/metformin Targets Glycemic Goal in Type 2 Diabetes

September 16, 2015

Diabetes

Long-acting basal insulin controls HbA1c as well as glargine

September 16, 2015

Diabetes

Long-acting Basal Insulin Controls A1C as Well as Glargine

September 16, 2015

Diabetes

EASD: Intranasal glucagon reverses hypoglycemia in children and adolescents

September 16, 2015

Diabetes

EASD: High HbA1c linked to elevated dementia risk in patients with 2DM

September 16, 2015

Diabetes

EASD: High A1C Linked to Elevated Dementia Risk in Patients With T2DM

September 16, 2015

Diabetes